Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 34Carcinoma, Non-Small-Cell Lung 26Breast Neoplasms 26Lung Neoplasms 24Colonic Neoplasms 18Head and Neck Neoplasms 16Rectal Neoplasms 14Prostatic Neoplasms 11Sarcoma 10Neoplasm Metastasis 9Pancreatic Neoplasms 8Neoplasms 7Mouth Neoplasms 7Melanoma 7Esophageal Neoplasms 7Adenomatous Polyposis Coli 7Ovarian Neoplasms 6Glioblastoma 6Precancerous Conditions 5Neuroblastoma 5Liver Neoplasms 5Central Nervous System Neoplasms 5Carcinoma 5Unspecified Adult Solid Tumor, Protocol Specific 4Triple Negative Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Recurrence 4Oropharyngeal Neoplasms 4Laryngeal Neoplasms 4Hypopharyngeal Neoplasms 4

Interventions

alvimopan 5Irinotecan 4Oxaliplatin 3Capecitabine 3Bevacizumab 3Surveys and Questionnaires 2Leucovorin 2Fluorouracil 2Drug Therapy 2Cyclophosphamide 2Colonoscopy 2Cetuximab 2Aspirin 2repotrectinib 1pralsetinib 1pembrolizumab 1napabucasin 1lutetium Lu 177 dotatate 1guadecitabine 1encorafenib 1copper dotatate CU-64 1alectinib 1Ursodeoxycholic Acid 1Surgical Procedures, Operative 1Pemetrexed 1Oviposition 1Ocoxin 1Lutetium-177 1Lutetium 1Low Density Lipoprotein Receptor-Related Protein-1 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Intestinal Diseases × Celecoxib × Clear all
NCT00808743 2013-05-16

PreDuoFAP

Radboud University Medical Center

Phase 2/3 Completed
37 enrolled
Gastrointestinal

Adenoma, Digestive System Diseases, Digestive System Neoplasms, Duodenal Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplastic Syndromes, Hereditary, Adenomatous Polyposis Coli, Polyps, Adenomatous Polyps, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon âš¡